Immunotherapy has emerged as a revolutionary approach to cancer treatment, leveraging the body's immune system to combat malignancy. This article provides a comprehensive overview of immunotherapy, its mechanisms, and clinical applications, offering physicians an essential guide to this groundbreaking field.
Immunotherapy, also known as biological therapy, involves the use of living organisms, substances derived from them, or laboratory-produced versions of such substances to enhance or restore immune system function. It can either stimulate the immune system to work harder or smarter to attack cancer cells or provide the immune system with components, such as man-made immune system proteins.
Immunotherapy is categorized into several types: Monoclonal antibodies, immune checkpoint inhibitors, cancer vaccines, and non-specific immunotherapies. Each type works differently and is used in different cancer types. Monoclonal antibodies are laboratory-produced molecules engineered to serve as substitute antibodies that can restore, enhance or mimic the immune system's attack on cancer cells. Immune checkpoint inhibitors are drugs designed to unleash an immune system attack on cancer cells. Cancer vaccines are substances introduced into the body to cause an immune response against certain diseases. Non-specific immunotherapies generally boost the immune system in a general way, which can still help the immune system attack cancer cells.
Immunotherapy holds a critical position in modern healthcare due to its potential to treat a wide range of cancers. Its advantages include fewer side effects, a more targeted approach, and the potential for a durable response. However, not all patients respond to immunotherapy, and its use can sometimes lead to overactivation of the immune system, causing severe side effects.
Immunotherapy has transformed the landscape of cancer treatment, offering hope where traditional therapies have failed. As our understanding of the immune system and cancer biology continues to grow, so will the potential of immunotherapy. Physicians must stay updated with this rapidly evolving field to provide the best care for their patients.
1.
For MDS-Related Anemia, Telomerase Inhibitor Approved.
2.
Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma
3.
Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.
4.
Treating Depression: Crucial for Recovery From Fibromyalgia
5.
In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.
1.
Empowering Oncology with Data: Cloud Security, Real-World Evidence, and Clinical Insights
2.
Immune Regulation of Blood Cell Development
3.
Exploring the Effects of Radiation Therapy on Cystitis: A Journey to Better Health
4.
Transformative Frameworks in Oncology for Better Care
5.
Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
2.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
3.
Understanding the causes of anemia in adults beyond nutritional deficiencies
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
5.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation